Finally, newer classes of drugs licensed for use in people with diabetes, such as GLP-1 receptor agonists and SGLT2 inhibitors, reduce blood pressure and the risk of cardiovascular events.31 The gene discussed is GLP1R; the disease is diabetes mellitus.